AGF Investments LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,434
| Closed | -$887K | – | 387 |
|
|
2022
Q1 | $887K | Buy |
+5,434
| New | +$887K | 0.07% | 127 |
|
|
2021
Q2 | – | Sell |
-4,132
| Closed | -$583K | – | 429 |
|
|
2021
Q1 | $583K | Sell |
4,132
-1,979
| -32% | -$279K | 0.07% | 202 |
|
|
2020
Q4 | $794K | Sell |
6,111
-4,226
| -41% | -$549K | 0.09% | 147 |
|
|
2020
Q3 | $1.51M | Buy |
10,337
+1,027
| +11% | +$150K | 0.17% | 56 |
|
|
2020
Q2 | $1.38M | Buy |
9,310
+9,246
| +14,447% | +$1.37M | 0.14% | 112 |
|
|
2020
Q1 | $7K | Buy |
+64
| New | +$7K | ﹤0.01% | 494 |
|
|
2018
Q2 | – | Sell |
-262
| Closed | -$24K | – | 826 |
|
|
2018
Q1 | $24K | Buy |
262
+106
| +68% | +$9.71K | ﹤0.01% | 443 |
|
|
2017
Q4 | $20K | Buy |
156
+70
| +81% | +$8.97K | ﹤0.01% | 424 |
|
|
2017
Q3 | $11K | Buy |
+86
| New | +$11K | ﹤0.01% | 448 |
|